CorMedix
CRMD
#7106
Rank
$0.62 B
Marketcap
$7.91
Share price
-0.38%
Change (1 day)
-28.48%
Change (1 year)

Operating Margin for CorMedix (CRMD)

Operating Margin as of July 2026 (TTM): 46.24%

According to CorMedix's latest financial reports and stock price the company's current Operating Margin is 46.24%. At the end of 2025 the company had an Operating Margin of 48.13%.

Operating Margin history for CorMedix from 2014 to 2026

Operating Margin at the end of each year

Year Operating Margin Change
202548.13%-208.26%
2024-44.45%
2022-46,305.23%200.11%
2021-15,429.47%35.72%
2020-11,368.54%49.83%
2019-7,587.87%21.55%
2018-6,242.40%-37.72%
2017-10,023.45%-8.85%
2016-10,996.46%27.05%
2015-8,655.37%-19.9%
2014-10,806.25%-97.63%
2013-456,426.69%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Becton Dickinson
BDX
7.69%-83.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Utah Medical Products
UTMD
35.79%-22.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
11.74%-74.61%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.